A Phase II Study of Carelizumab Combined With Irinotecan and Apatinib of Second-line Treatment for Advanced Gastric Cancer
Clinical trial NCT04934618 · UNKNOWN
Trial details
- NCT number
- NCT04934618
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-19
- Primary completion
- 2023-05-19
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.